Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 317


NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies.

Ivashko-Pachima Y, Maor-Nof M, Gozes I.

PLoS One. 2019 Mar 13;14(3):e0213666. doi: 10.1371/journal.pone.0213666. eCollection 2019.


The blood-brain barrier and beyond: Nano-based neuropharmacology and the role of extracellular matrix.

Henrich-Noack P, Nikitovic D, Neagu M, Docea AO, Engin AB, Gelperina S, Shtilman M, Mitsias P, Tzanakakis G, Gozes I, Tsatsakis A.

Nanomedicine. 2019 Feb 10. pii: S1549-9634(19)30028-0. doi: 10.1016/j.nano.2019.01.016. [Epub ahead of print]


Neuropeptides: From Bench to Bedside.

Shioda S, Gozes I.

Curr Pharm Des. 2018;24(33):3867. doi: 10.2174/138161282433190109122611.


Cellular and animal models of skin alterations in the autism-related ADNP syndrome.

Mollinedo P, Kapitansky O, Gonzalez-Lamuño D, Zaslavsky A, Real P, Gozes I, Gandarillas A, Fernandez-Luna JL.

Sci Rep. 2019 Jan 24;9(1):736. doi: 10.1038/s41598-018-36859-2.


The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.

Sragovich S, Malishkevich A, Piontkewitz Y, Giladi E, Touloumi O, Lagoudaki R, Grigoriadis N, Gozes I.

Transl Psychiatry. 2019 Jan 15;9(1):2. doi: 10.1038/s41398-018-0357-6.


Atypical Auditory Brainstem Response and Protein Expression Aberrations Related to ASD and Hearing Loss in the Adnp Haploinsufficient Mouse Brain.

Hacohen-Kleiman G, Yizhar-Barnea O, Touloumi O, Lagoudaki R, Avraham KB, Grigoriadis N, Gozes I.

Neurochem Res. 2019 Jan 18. doi: 10.1007/s11064-019-02723-6. [Epub ahead of print]


Cancer-associated stroke: Pathophysiology, detection and management (Review).

Dardiotis E, Aloizou AM, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G, Libra M, Kyritsis AP, Brotis AG, Aschner M, Gozes I, Bogdanos DP, Spandidos DA, Mitsias PD, Tsatsakis A.

Int J Oncol. 2019 Mar;54(3):779-796. doi: 10.3892/ijo.2019.4669. Epub 2019 Jan 2.


ADNP Regulates Cognition: A Multitasking Protein.

Gozes I.

Front Neurosci. 2018 Nov 26;12:873. doi: 10.3389/fnins.2018.00873. eCollection 2018. No abstract available.


NAP Protects against Tau Hyperphosphorylation Through GSK3.

Ivashko-Pachima Y, Gozes I.

Curr Pharm Des. 2018;24(33):3868-3877. doi: 10.2174/1381612824666181112105954.


Severity dependent distribution of impairments in PSP and CBS: Interactive visualizations.

Brittain C, McCarthy A, Irizarry MC, McDermott D, Biglan K, Höglinger GU, Lorenzl S, Del Ser T, Boxer AL; AL-108-231 Study Group; PROPSPERA investigators; 4RNTI-1authors; Tau Restoration on PSP (TAUROS) Investigators.

Parkinsonism Relat Disord. 2018 Sep 4. pii: S1353-8020(18)30384-5. doi: 10.1016/j.parkreldis.2018.08.025. [Epub ahead of print]


Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome.

Hacohen-Kleiman G, Sragovich S, Karmon G, Gao AYL, Grigg I, Pasmanik-Chor M, Le A, Korenková V, McKinney RA, Gozes I.

J Clin Invest. 2018 Nov 1;128(11):4956-4969. doi: 10.1172/JCI98199. Epub 2018 Sep 24.


Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice.

Ziv Y, Rahamim N, Lezmy N, Even-Chen O, Shaham O, Malishkevich A, Giladi E, Elkon R, Gozes I, Barak S.

Neuropsychopharmacology. 2019 Jan;44(2):415-424. doi: 10.1038/s41386-018-0132-7. Epub 2018 Jun 27.


Anti-inflammatory Effects of the Octapeptide NAP in Human Microbiota-Associated Mice Suffering from Subacute Ileitis.

Escher U, Giladi E, Dunay IR, Bereswill S, Gozes I, Heimesaat MM.

Eur J Microbiol Immunol (Bp). 2018 May 23;8(2):34-40. doi: 10.1556/1886.2018.00006. eCollection 2018 Jun 25.


SIRT1, miR-132 and miR-212 link human longevity to Alzheimer's Disease.

Hadar A, Milanesi E, Walczak M, Puzianowska-Kuźnicka M, Kuźnicki J, Squassina A, Niola P, Chillotti C, Attems J, Gozes I, Gurwitz D.

Sci Rep. 2018 May 31;8(1):8465. doi: 10.1038/s41598-018-26547-6.


ADNP, a Microtubule Interacting Protein, Provides Neuroprotection Through End Binding Proteins and Tau: An Amplifier Effect.

Gozes I, Ivashko-Pachima Y, Sayas CL.

Front Mol Neurosci. 2018 May 1;11:151. doi: 10.3389/fnmol.2018.00151. eCollection 2018. No abstract available.


Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP.

Van Dijck A, Vulto-van Silfhout AT, Cappuyns E, van der Werf IM, Mancini GM, Tzschach A, Bernier R, Gozes I, Eichler EE, Romano C, Lindstrand A, Nordgren A; ADNP Consortium, Kvarnung M, Kleefstra T, de Vries BBA, Küry S, Rosenfeld JA, Meuwissen ME, Vandeweyer G, Kooy RF.

Biol Psychiatry. 2019 Feb 15;85(4):287-297. doi: 10.1016/j.biopsych.2018.02.1173. Epub 2018 Mar 15.


Correction to: The Compassionate Side of Neuroscience: Tony Sermone's Undiagnosed Genetic Journey-ADNP Mutation.

Gozes I, Helsmoortel C, Vandeweyer G, Van der Aa N, Kooy F, Bedrosian-Sermone S.

J Mol Neurosci. 2018 Feb;64(2):331. doi: 10.1007/s12031-018-1028-z.


The octapetide NAP alleviates intestinal and extra-intestinal anti-inflammatory sequelae of acute experimental colitis.

Heimesaat MM, Giladi E, Kühl AA, Bereswill S, Gozes I.

Peptides. 2018 Mar;101:1-9. doi: 10.1016/j.peptides.2017.12.023. Epub 2017 Dec 27.


CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP.

Rojas JC, Bang J, Lobach IV, Tsai RM, Rabinovici GD, Miller BL, Boxer AL; AL-108-231 Investigators.

Neurology. 2018 Jan 23;90(4):e273-e281. doi: 10.1212/WNL.0000000000004859. Epub 2017 Dec 27.


Tau Diagnostics and Clinical Studies.

Gozes I, Höglinger G, Quinn JP, Hooper NM, Höglund K.

J Mol Neurosci. 2017 Oct;63(2):123-130. doi: 10.1007/s12031-017-0983-0.


Supplemental Content

Loading ...
Support Center